Safety of CRIS100 on Treatment Spinal Cord Injury

Summary

The goal of this clinical trial is to test CRIS100 treatment in participants with acute thoracic spinal cord injury. The main questions it aims to answer are: * safety of CRIS100 * efficacy of CRIS100 Participants will receive 100 mcg CRIS100 in the epicenter of the spinal injury, within 72 hours of the trauma.

Timeline

Start

2026-04

Primary completion

2027-05

Completion

2027-05

Drugs

Indications